Register
FDA updates warnings for fluoroquinolones on risks of mental health and hypoglycemia |
Journal Updates
eMediNexus Coverage from: 
FDA updates warnings for fluoroquinolones on risks of mental health and hypoglycemia
eMediNexus,  11 July 2018
remove_red_eye 790 Views
#Pathology and Lab Medicine #Psychiatry

1 Read Comments                

The US Food and Drug Administration (FDA) is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!